| Epidemiology of severe sepsis FB Mayr, S Yende, DC Angus Virulence 5 (1), 4-11, 2014 | 1623 | 2014 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... MedRxiv, 2021.01. 07.21249390, 2021 | 1400 | 2021 |
| Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis FB Mayr, S Yende, WT Linde-Zwirble, OM Peck-Palmer, AE Barnato, ... Jama 303 (24), 2495-2503, 2010 | 967 | 2010 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 647 | 2021 |
| Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans AO Spiel, FB Mayr, C Firbas, P Quehenberger, B Jilma Journal of Thrombosis and Haemostasis 4 (2), 411-416, 2006 | 231 | 2006 |
| Effects of carbon monoxide inhalation during experimental endotoxemia in humans FB Mayr, A Spiel, J Leitner, C Marsik, P Germann, R Ullrich, O Wagner, ... American journal of respiratory and critical care medicine 171 (4), 354-360, 2005 | 228 | 2005 |
| Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559) RS Hotchkiss, E Colston, S Yende, DC Angus, LL Moldawer, ED Crouser, ... Critical care medicine 47 (5), 632-642, 2019 | 201 | 2019 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 200 | 2021 |
| Risk of cardiovascular events in survivors of severe sepsis S Yende, W Linde-Zwirble, F Mayr, LA Weissfeld, S Reis, DC Angus American journal of respiratory and critical care medicine 189 (9), 1065-1074, 2014 | 190 | 2014 |
| Coagulation management during liver transplantation K Görlinger Hämostaseologie 26 (S 02), S64-S75, 2006 | 189 | 2006 |
| Proportion and cost of unplanned 30-day readmissions after sepsis compared with other medical conditions FB Mayr, VB Talisa, V Balakumar, CCH Chang, M Fine, S Yende Jama 317 (5), 530-531, 2017 | 176 | 2017 |
| Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab RS Hotchkiss, E Colston, S Yende, ED Crouser, GS Martin, T Albertson, ... Intensive care medicine 45, 1360-1371, 2019 | 156 | 2019 |
| Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin RA Reiter, F Mayr, H Blazicek, E Galehr, P Jilma-Stohlawetz, ... Blood 102 (13), 4594-4599, 2003 | 146 | 2003 |
| Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths S Yende, G D'Angelo, F Mayr, JA Kellum, L Weissfeld, AM Kaynar, ... PloS one 6 (8), e22847, 2011 | 125 | 2011 |
| SARS-CoV-2 vaccine effectiveness in a high-risk national population in a real-world setting AA Butt, SB Omer, P Yan, OS Shaikh, FB Mayr Annals of Internal Medicine 174 (10), 1404-1408, 2021 | 123 | 2021 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 103 | 2023 |
| Do hospitals provide lower quality of care to black patients for pneumonia? FB Mayr, S Yende, G D'Angelo, AE Barnato, JA Kellum, L Weissfeld, ... Critical care medicine 38 (3), 759-765, 2010 | 99 | 2010 |
| Differences in immune response may explain lower survival among older men with pneumonia MC Reade, S Yende, G D'Angelo, L Kong, JA Kellum, AE Barnato, ... Critical care medicine 37 (5), 1655-1662, 2009 | 90 | 2009 |
| The interleukin-6 G (− 174) C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans G Endler, C Marsik, C Joukhadar, R Marculescu, F Mayr, C Mannhalter, ... Clinical chemistry 50 (1), 195-200, 2004 | 90 | 2004 |
| Identification of LIN28B-bound mRNAs reveals features of target recognition and regulation R Graf, M Munschauer, G Mastrobuoni, F Mayr, U Heinemann, S Kempa, ... RNA biology 10 (7), 1146-1159, 2013 | 86 | 2013 |
